Follicular thyroid cancer pathophysiology: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
==Pathogenesis== | ==Pathogenesis== | ||
[[Image:Follicular adenoma of the thyroid.jpg|thumb|left|Gross pathological section of a follicular thyroid carcinoma (tumor at the bottom).]] | [[Image:Follicular adenoma of the thyroid.jpg|thumb|left|Gross pathological section of a follicular thyroid carcinoma (tumor at the bottom).]] | ||
* Follicular thyroid cancer is the second most common type of cancer. | * Follicular thyroid cancer is the second most common type of cancer. It constitute about 15% of thyroid cancers. | ||
* This occurs more commonly in women of over 50 years old. [[Thyroglobulin]] (Tg) can be used as a [[tumor marker]] for well-differentiated follicular thyroid cancer. Follicular carcinoma tends to metastasize to the lungs and bone via the bloodstream, while papillary thyroid carcinoma commonly metastasizes to cervical lymph nodes.Unlike papillary it metastasises late to lymph nodes, with only 5-10% of patients having nodal metastases at the time of diagnosis. Haematogenous spread is however much more common with 20% or so of patients having distant haematogenous metastases at presentation.<ref name=Radiopaedia 2015 Papillary thyroid cancer | * This occurs more commonly in women of over 50 years old. [[Thyroglobulin]] (Tg) can be used as a [[tumor marker]] for well-differentiated follicular thyroid cancer. Follicular carcinoma tends to metastasize to the lungs and bone via the bloodstream, while papillary thyroid carcinoma commonly metastasizes to cervical lymph nodes.Unlike papillary it metastasises late to lymph nodes, with only 5-10% of patients having nodal metastases at the time of diagnosis. Haematogenous spread is however much more common with 20% or so of patients having distant haematogenous metastases at presentation.<ref name=Radiopaedia 2015 Papillary thyroid cancer | ||
>{{cite web | title = Radiopedia 2015 Follicular thyroid cancer [Dr Matt A. Morgan and Dr Frank Gaillard]| url = http://radiopaedia.org/articles/follicular-thyroid-cancer }}</ref> | >{{cite web | title = Radiopedia 2015 Follicular thyroid cancer [Dr Matt A. Morgan and Dr Frank Gaillard]| url = http://radiopaedia.org/articles/follicular-thyroid-cancer }}</ref> |
Revision as of 13:17, 27 October 2015
Follicular thyroid cancer Microchapters |
Differentiating Follicular thyroid cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Follicular thyroid cancer pathophysiology On the Web |
American Roentgen Ray Society Images of Follicular thyroid cancer pathophysiology |
Risk calculators and risk factors for Follicular thyroid cancer pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Pathogenesis
- Follicular thyroid cancer is the second most common type of cancer. It constitute about 15% of thyroid cancers.
- This occurs more commonly in women of over 50 years old. Thyroglobulin (Tg) can be used as a tumor marker for well-differentiated follicular thyroid cancer. Follicular carcinoma tends to metastasize to the lungs and bone via the bloodstream, while papillary thyroid carcinoma commonly metastasizes to cervical lymph nodes.Unlike papillary it metastasises late to lymph nodes, with only 5-10% of patients having nodal metastases at the time of diagnosis. Haematogenous spread is however much more common with 20% or so of patients having distant haematogenous metastases at presentation.
Genetics
- The Ras oncogene is positive in a significant proportion of individuals
- Other genes involved in the pathogenesis of follicular thyroid cancer are as follows.
- RET/PTC (translocation) associated with MAPK and PI3K-AKT signaling pathways
- HRAS, KRAS, NRAS (mutation) associated with MAPK and PI3K-AKT signaling pathways
- PAX8/PPARγ (translocation) associated with PAX8-associated nuclear transcription signaling pathways
- PTEN (mutation) associated with PI3K-AKT signaling pathways
- PTEN (deletion) associated with PI3K-AKT signaling pathways
- IDH1 (mutation) assciated with IDH1-associated metabolic pathways signaling pathways
Associated Conditions
- Cowden disease
- Carney complex, type I
Gross Pathology
Microscopic Pathology
- It is not possible to distinguish between follicular adenoma and carcinoma on cytological grounds. If fine needle aspiration cytology (FNAC) suggests follicular neoplasm, thyroid lobectomy should be performed to establish the histopathological diagnosis.
- Trabecular, solid, follicular tumor cells that invade tumor capsule or surrounding vascular structures.